Korro Bio

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Korro Bio and other ETFs, options, and stocks.

About KRRO

Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B.

CEO

Ram Aiyar

CEORam Aiyar

Employees

104

Employees104

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2018

Founded2018

Employees

104

Employees104

KRRO Key Statistics

Market cap

120.84M

Market cap120.84M

Price-Earnings ratio

-1.34

Price-Earnings ratio-1.34

Dividend yield

—

Dividend yield—

Average volume

107.61K

Average volume107.61K

High today

$13.32

High today$13.32

Low today

$12.51

Low today$12.51

Open price

$13.14

Open price$13.14

Volume

131.78K

Volume131.78K

52 Week high

$98.00

52 Week high$98.00

52 Week low

$10.29

52 Week low$10.29

Analyst ratings

100%

of 10 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own KRRO. This list is generated using Robinhood data, and it’s not a recommendation.

Korro Bio

Why Robinhood?

Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B. Show more

KRRO Key Statistics

Analyst ratings

100%

People also own

Korro Bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of a new class of genetic medicines based on editing RNA. The company was founded by Nessan Bermingham, Jean-Francois B.